A cause of hyperinflammatory response in lethal COVID-19 identified
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Apr-2025 00:08 ET (30-Apr-2025 04:08 GMT/UTC)
Against the backdrop of an alarming increase in the number of people under 50 being diagnosed with bowel cancer, researchers are urging people to bump up their fibre intake and improve their eating habits if they want to reduce their risk of deadly digestive cancers.
Two studies by Flinders University expand on existing evidence that a diet rich in fruits, vegetables, whole grains, fish, legumes and dairy may protect against the risk of gastrointestinal (GI) cancers - including bowel - and improve the outcomes of these diseases.
Kumamoto University researchers have identified a powerful antibody that can neutralize a wide range of SARS-CoV-2 variants, including the elusive Omicron subvariants.
A new chimeric antigen receptor T cell (CAR-T) therapy has delivered promising results in treating patients with an aggressive blood cancer, in results from a clinical trial led by researchers at UCL and UCLH.
Ewing sarcoma is a tumour of the bones and soft tissues that occurs in children and young people. A quarter of patients do not respond well to therapy.
The group led by Ana Losada, at Spain’s National Cancer Research Centre (CNIO), has discovered an alteration in the most aggressive cases that affects genes never previously related to this disease.
This finding expands the list of potential prognostic markers and therapeutic targets in the most aggressive cases of Ewing sarcoma.
The new research is published in ‘EMBO Reports’.